Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2015 5
2016 4
2017 3
2018 2
2019 4
2020 15
2021 20
2022 24
2023 10
2024 15
2025 15
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.
Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D; evolutionRMS investigators. Montalban X, et al. Lancet Neurol. 2024 Nov;23(11):1119-1132. doi: 10.1016/S1474-4422(24)00328-4. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307151 Clinical Trial.
CD4+FOXP3Exon2+ regulatory T cell frequency predicts breast cancer prognosis and survival.
Fusco C, Di Rella F, Liotti A, Colamatteo A, Ferrara AL, Gigantino V, Collina F, Esposito E, Donzelli I, Porcellini A, Feola A, Micillo T, Perna F, Garziano F, Maniscalco GT, Varricchi G, Mottola M, Zuccarelli B, De Simone B, di Bonito M, Matarese G, Accurso A, Pontillo M, Russo D, Insabato L, Spaziano A, Cantone I, Pezone A, De Rosa V. Fusco C, et al. Among authors: maniscalco gt. Sci Adv. 2025 Jan 17;11(3):eadr7934. doi: 10.1126/sciadv.adr7934. Epub 2025 Jan 15. Sci Adv. 2025. PMID: 39813341 Free PMC article.
Multiple Sclerosis Progression and Relapse Activity in Children.
Iaffaldano P, Portaccio E, Lucisano G, Simone M, Manni A, Guerra T, Paolicelli D, Betti M, De Meo E, Pastò L, Razzolini L, Rocca MA, Ferrè L, Brescia Morra V, Patti F, Zaffaroni M, Gasperini C, De Luca G, Ferraro D, Granella F, Pozzilli C, Romano S, Gallo P, Bergamaschi R, Coniglio MG, Lus G, Vianello M, Banfi P, Lugaresi A, Totaro R, Spitaleri D, Cocco E, Di Palma F, Maimone D, Valentino P, Torri Clerici V, Protti A, Maniscalco GT, Salemi G, Pesci I, Aguglia U, Lepore V, Filippi M, Trojano M, Amato MP; Italian Multiple Sclerosis Register. Iaffaldano P, et al. Among authors: maniscalco gt. JAMA Neurol. 2024 Jan 1;81(1):50-58. doi: 10.1001/jamaneurol.2023.4455. JAMA Neurol. 2024. PMID: 38010712 Free PMC article.
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and Discrepancies.
Carta S, Sechi E, Dinoto A, Mancinelli C, Greco G, Maniscalco GT, Cornacchini S, Giannoccaro MP, Calabria F, Marziali A, Masciocchi S, Risi M, Cossu A, Volonghi I, Cantalupo G, Zoccarato M, Orlandi R, Del Zotto E, Ferraro D, Trentinaglia M, De Biase S, Grazian L, Caleri F, Bianchi MR, Rossi P, Virgilio E, Capobianco M, Cortese R, Tortorella C, Rossi F, De Luca G, Perelli A, Bozzetti S, Zuliani L, Nosadini M, Sartori S, Brambilla L, Gajofatto A, Vogrig A, Massacesi L, Damato V, Gastaldi M, Mariotto S. Carta S, et al. Among authors: maniscalco gt. Neurol Neuroimmunol Neuroinflamm. 2025 Sep;12(5):e200456. doi: 10.1212/NXI.0000000000200456. Epub 2025 Aug 19. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 40829090 Free PMC article.
Epigenetics: An opportunity to shape innate and adaptive immune responses.
Liotti A, Ferrara AL, Loffredo S, Galdiero MR, Varricchi G, Di Rella F, Maniscalco GT, Belardo M, Vastano R, Prencipe R, Pignata L, Romano R, Spadaro G, de Candia P, Pezone A, De Rosa V. Liotti A, et al. Among authors: maniscalco gt. Immunology. 2022 Dec;167(4):451-470. doi: 10.1111/imm.13571. Epub 2022 Sep 26. Immunology. 2022. PMID: 36043705 Free article. Review.
Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants.
De Rosa V, Galgani M, Porcellini A, Colamatteo A, Santopaolo M, Zuchegna C, Romano A, De Simone S, Procaccini C, La Rocca C, Carrieri PB, Maniscalco GT, Salvetti M, Buscarinu MC, Franzese A, Mozzillo E, La Cava A, Matarese G. De Rosa V, et al. Among authors: maniscalco gt. Nat Immunol. 2015 Nov;16(11):1174-84. doi: 10.1038/ni.3269. Epub 2015 Sep 28. Nat Immunol. 2015. PMID: 26414764 Free PMC article.
The Italian Multiple Sclerosis Register Experience With Cladribine: Impact on Relapses, PIRA, and Treatment Sequencing Strategies Evaluation.
Guerra T, Copetti M, Zanetta C, Patti F, Chisari CG, Barbuti E, Portaccio E, Foschi M, Conte A, Ferraro D, Cocco EE, Fantozzi R, Maniscalco GT, Salemi G, Tortorella C, Paolicelli D, Filippi M, Amato MP, Trojano M, Iaffaldano P; Italian Multiple Sclerosis & Related Disorders Register (RISM). Guerra T, et al. Among authors: maniscalco gt. Neurol Neuroimmunol Neuroinflamm. 2025 Jul;12(4):e200415. doi: 10.1212/NXI.0000000000200415. Epub 2025 Jun 5. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 40472290 Free PMC article.
Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.
Haggiag S, Prosperini L, Filippi M, Rocca MA, Iaffaldano P, Patti F, Inglese M, Borriello G, Totaro R, Lus G, Fantozzi R, Brescia Morra V, Romano S, Frau J, Marfia GA, Maniscalco GT, Amato MP, Di Sapio A, De Luca G, Crisafulli SG, Curti E, Foschi M, Cavalla P, Salemi G, Conte A, Valentino P, Ferraro D, Lugaresi A, Realmuto S, Perini P, Ferraro E, Montepietra S, Avolio C, Vianello M, Gazzola P, Marinelli F, Pasquali L, Bucello S, Vecchio D, Protti A, Sangalli F, Rovaris M, Grimaldi L, De Riz M, Barone P, Scarano V, Ardito B, Sinisi L, Immovilli P, Pesci I, Colombo E, Capobianco MA, Fioretti C, Coniglio MG, Giordano A, Tassinari T, Cargnelutti D, Matta F, Falcini M, Gatto M, Mascoli N, Balgera R, Sessa E, Iodice R, Solaro C, Plewnia K, Santangelo M, Barcella V, Ferrò MT, Sica F, Cerqua R, Santuccio G, Corea F, Leone A, Nasuelli D, Rini AM, Brichetto G, Cottone S, Ulivelli M, Pizzorno M, Rossi P, Milano E, Zuliani L, Ruggieri S, Gasperini C, Trojano M, Tortorella C. Haggiag S, et al. Among authors: maniscalco gt. JAMA Netw Open. 2025 Nov 3;8(11):e2541025. doi: 10.1001/jamanetworkopen.2025.41025. JAMA Netw Open. 2025. PMID: 41182765 Free PMC article.
Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 monoclonal antibodies: a systematic review and meta-analysis of observational studies.
Scavone C, Cagnotta C, Sportiello L, Maniscalco GT, Ragone A, Frasca M, Rinaldi B, Capuano A. Scavone C, et al. Among authors: maniscalco gt. Expert Opin Drug Saf. 2025 Oct 24:1-21. doi: 10.1080/14740338.2025.2574668. Online ahead of print. Expert Opin Drug Saf. 2025. PMID: 41081871 Review.
Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple Sclerosis.
Portaccio E, Betti M, De Meo E, Pastò L, Prestipino E, Lugaresi A, Cocco E, De Luca G, Patti F, Torri Clerici VLAM, Ferraro D, Brescia Morra V, Salemi G, Vianello M, Cerqua R, Inglese M, Pasanisi MB, Perini P, Romano S, Pozzilli C, Tortorella C, Di Sapio A, Annovazzi P, Simone M, Iaffaldano P, Rocca MA, Filippi M, Trojano M, Amato MP; Italian Multiple Sclerosis and Related Disorders Register. Portaccio E, et al. Neurology. 2025 Oct 21;105(8):e213977. doi: 10.1212/WNL.0000000000213977. Epub 2025 Sep 22. Neurology. 2025. PMID: 40982769 Free PMC article.
98 results